Download Sample
Add to CartGlobal Intravascular Catheters Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Short, and Integrated/Closed PIVCs.By Application;
Oncology, Gastroenterology, Renal Disease, Infectious Diseases, and Others.By End Use;
Hospitals, Clinics, ASC, and Homecare.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Intravascular Catheters Market (USD Million), 2021 - 2031
In the year 2024, the Global Intravascular Catheters Market was valued at USD 5,040.04 million. The size of this market is expected to increase to USD 8,979.31 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
Global Intravascular Catheters Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 8.6 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 8.6 % |
| Market Size (2024) | USD 5,040.04 Million |
| Market Size (2031) | USD 8,979.31 Million |
| Market Concentration | Medium |
| Report Pages | 364 |
Major Players
- Cook Medical
- Smiths Medical
- Edwards Life Sciences Corporation
- Medtronic Inc.
- Johnson & Johnson
- McKesson Medical Surgical Inc.
- Terumo Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Intravascular Catheters Market
Fragmented - Highly competitive market without dominant players
The intravascular catheters is rising steadily, fueled by their vital role in managing hospitalized patients. With over 70% of inpatients requiring intravenous access, these catheters are now core components of acute and chronic treatment protocols in modern healthcare systems.
Chronic Disease Burden Driving Device Utilization
The increasing prevalence of long-term conditions like cardiovascular disorders, cancer, and kidney disease has led to wider use of intravascular catheters. Utilization for drug administration, fluid management, and patient monitoring has surged by more than 60%, reflecting the growing need for continuous vascular access solutions.
Surge in Surgical Procedures and ICU Cases
The global rise in surgeries and intensive care admissions continues to boost catheter adoption. Approximately 80% of patients in critical care settings now receive catheter-based treatments, underscoring their essential role in managing life-threatening and post-operative conditions.
Innovation Enhancing Device Safety and Efficiency
Technological breakthroughs in catheter design—such as antimicrobial coatings, precision-tipped catheters, and safety features—have greatly enhanced both performance and user confidence. These improvements have contributed to a 45% increase in adoption among care providers seeking safer, more effective vascular access tools.
Rise in Outpatient and Home Care Applications
The shift toward ambulatory care and home-based medical services is reshaping market dynamics. Intravascular catheter usage in non-hospital settings has grown by nearly 50%, as patients and providers alike embrace flexible care delivery models beyond traditional hospital environments.
Global Intravascular Catheters Market Recent Developments
-
In May 2022, Cook Medical launched the MINC+ Benchtop Incubator for IVF facilities in the United States and Canada. The MINC+ is the next generation of the Mini Incubator. The DishTrace technology, which combines capability through the incubator screen and computer system software to provide a wide range of dish-data management features, is also included with the MINC+ incubator.
-
In June 2022, Teleflex Incorporated launched its Arrow Pressure Injectable Midline Catheter in both Australia and New Zealand. This strategic addition enhances the company’s existing Midline catheter portfolio, aiming to address the evolving needs of healthcare providers. Engineered for pressure injection capability, the device supports greater clinical versatility while focusing on improving patient safety. With this expansion, Teleflex continues to reinforce its commitment to delivering high-performance vascular access solutions tailored for optimized patient outcomes. This move reflects the brand’s dedication to innovation in minimally invasive care.
Segment Analysis
In this report, the Global Intravascular Catheters Market has been segmented by Product, End Use, Application and Geography.
Global Intravascular Catheters Market, Segmentation by Product
The Global Intravascular Catheters Market has been segmented by Product into Short, and Integrated/Closed PIVCs.
Short PIVCs
Short Peripheral Intravenous Catheters (PIVCs) are commonly used for temporary intravenous access, typically ranging from a few hours to a few days. These catheters are ideal for administering medications, fluids, and blood products quickly and efficiently. Currently, Short PIVCs dominate the intravascular catheter market, holding a substantial share of around 60%. Their widespread adoption is due to their simplicity, cost-effectiveness, and high success rates for short-term vascular access.
Integrated/Closed PIVCs
Integrated or Closed Peripheral Intravenous Catheters (PIVCs) feature advanced closed-system technology that helps reduce the risk of infections and complications, such as bloodstream infections. These catheters are equipped with built-in safety features like antiseptic ports, ensuring a sterile environment during insertion. The demand for Integrated/Closed PIVCs is steadily growing and now accounts for approximately 40% of the global intravascular catheter market, as healthcare professionals increasingly prioritize patient safety and infection prevention in medical procedures.
Global Intravascular Catheters Market, Segmentation by End Use
The Global Intravascular Catheters Market has been segmented by End Use into Hospitals, Clinics, ASC, and Homecare.
Hospitals
Hospitals represent the largest end-user segment for intravascular catheters, as they are essential for a wide range of medical treatments, including surgeries, intensive care, and emergency care. The demand for catheters in hospitals is driven by the need for both short-term and long-term vascular access. Hospitals account for approximately 50% of the global intravascular catheter market, due to their extensive use in critical and routine procedures.
Clinics
In clinics, intravascular catheters are primarily used for outpatient treatments, such as blood draws, intravenous medication administration, and short-term procedures. The demand in this segment is driven by the growing number of patients seeking less invasive, outpatient options for medical care. Clinics hold around 20% of the global intravascular catheter market, as more people choose clinic-based treatments for convenience and cost-effectiveness.
ASCs (Ambulatory Surgical Centers)
Ambulatory Surgical Centers (ASCs) are increasingly utilizing intravascular catheters for outpatient surgeries and procedures that require short-term vascular access. ASCs are gaining popularity due to their ability to offer cost-effective and efficient care for minor surgical interventions. ASCs contribute to about 15% of the global intravascular catheter market, driven by their ability to reduce healthcare costs and enhance patient convenience.
Homecare
Homecare services have seen significant growth in the demand for intravascular catheters as more patients receive long-term treatments, such as intravenous antibiotics, nutrition, and pain management, at home. This segment is expected to grow rapidly, representing approximately 15% of the market, as advances in home healthcare and patient monitoring technologies enable more complex treatments outside traditional healthcare settings.
Global Intravascular Catheters Market, Segmentation by Application
The Global Intravascular Catheters Market has been segmented by Application into Oncology, Gastroenterology, Renal Disease, Infectious Diseases, and Others.
Oncology
The demand for intravascular catheters in oncology continues to rise due to the growing number of cancer cases and the need for efficient and targeted therapies. These catheters are essential for administering chemotherapy, pain relief, and collecting blood samples. Oncology represents around 35% of the global intravascular catheter market, reflecting the critical need for reliable vascular access during cancer treatment.
Gastroenterology
In gastroenterology, intravascular catheters are crucial for managing conditions such as gastrointestinal bleeding and Crohn’s disease. They are used for drug delivery, nutritional support, and patient monitoring. The gastroenterology segment contributes to approximately 25% of the total market, driven by an increasing demand for minimally invasive treatment options in digestive health care.
Renal Disease
Renal diseases, particularly chronic kidney conditions, require intravascular catheters for dialysis procedures. These catheters provide safe and efficient vascular access for blood filtration treatments. The renal disease segment holds about 20% of the global market, reflecting the ongoing need for vascular access in dialysis and other renal therapies.
Infectious Diseases
Infectious diseases often demand long-term intravenous treatments, including antibiotics and fluids, making intravascular catheters vital for effective therapy. These catheters are used in the management of severe infections requiring sustained access to veins. The infectious disease sector accounts for approximately 15% of the intravascular catheter market, as healthcare professionals turn to intravenous methods for treating life-threatening conditions.
Others
The "Others" segment encompasses a wide range of applications, including ICU care, post-surgical treatment, and pain management. Though varied, this segment holds around 5% of the market share and caters to the need for specialized vascular access in diverse medical scenarios.
Global Intravascular Catheters Market, Segmentation by Geography
In this report, the Global Intravascular Catheters Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Intravascular Catheters Market Share (%), by Geographical Region, 2024
North America
North America holds the largest share in the global intravascular catheter market, driven by advanced healthcare infrastructure, high adoption of medical technologies, and significant healthcare spending. The region accounts for approximately 40% of the global market share. The demand for intravascular catheters in North America is fueled by the increasing prevalence of chronic diseases and the growing number of surgical procedures.
Europe
Europe is a major player in the intravascular catheter market, with countries such as Germany, the UK, and France leading the demand. The market in Europe is driven by a robust healthcare system, aging population, and advancements in healthcare technology. Europe holds about 30% of the global intravascular catheter market, benefiting from the rising need for minimally invasive medical treatments and the growing prevalence of cardiovascular diseases.
Asia Pacific
The Asia Pacific region is experiencing significant growth in the intravascular catheter market, driven by rapid urbanization, improving healthcare infrastructure, and increasing healthcare expenditures. With a large and diverse population, Asia Pacific is expected to hold around 20% of the global market. The region's demand is also fueled by a rising incidence of lifestyle diseases such as diabetes and hypertension, which require vascular access for treatment.
Middle East and Africa
The Middle East and Africa (MEA) market for intravascular catheters is growing at a steady pace, driven by advancements in healthcare and increasing access to medical services in emerging economies. This region accounts for approximately 5% of the global market. Factors such as the increasing number of hospitals, rising healthcare awareness, and an increasing incidence of chronic diseases contribute to the market's growth.
Latin America
Latin America’s intravascular catheter market is expanding as the region experiences growth in healthcare infrastructure and an increasing number of surgeries and medical procedures. Latin America holds around 5% of the global market share. The demand for intravascular catheters in this region is driven by the rising number of healthcare facilities, along with an increasing focus on improving healthcare access and quality.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Intravascular Catheters Market. These factors include; Market Drivers, Restraints and Opportunities.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Growing burden of iron deficiency disorders
- Rising CKD and dialysis-related anemia
- Demand for rapid iron repletion methods
- Advancements in intravenous iron formulations - Advancements in intravenous iron formulations are playing a crucial role in the growth of the global intravascular catheters market. As healthcare systems increasingly adopt more effective treatments for iron deficiency anemia, the demand for intravenous (IV) therapies has surged. Intravenous iron has become the preferred treatment option due to its faster absorption and more reliable results compared to oral iron supplements. These treatments are especially beneficial for patients who cannot tolerate oral iron or require rapid iron replenishment, such as those with chronic kidney disease or cancer patients undergoing chemotherapy. As these therapies gain popularity, the need for advanced intravascular catheters to administer these treatments effectively has significantly increased.
Recent innovations in intravenous iron formulations have made iron replacement therapies safer, more efficient, and better tolerated by patients. Newer formulations are designed to minimize side effects and enhance patient outcomes, making them more widely accepted in clinical settings. As healthcare providers increasingly turn to IV iron treatments, they rely more heavily on high-quality intravascular catheters to ensure precise and safe delivery. As these intravenous formulations continue to evolve, the demand for intravascular catheters will continue to grow, supporting the market's expansion.
Moreover, these advancements in intravenous iron therapies are improving patient compliance with treatment regimens. The availability of more convenient and less invasive methods for administering iron has made it easier for patients to stick to their prescribed treatments. This is especially important for individuals with chronic health conditions who need regular iron supplementation. The combination of effective IV iron formulations and efficient intravascular catheter delivery systems makes this treatment approach increasingly popular across various healthcare settings, from hospitals and outpatient clinics to home healthcare environments.
As iron deficiency continues to affect a large portion of the global population, especially in developing countries, the demand for intravenous iron treatments and associated intravascular catheters is expected to rise. Healthcare systems are recognizing the importance of treating iron deficiency more effectively, driving investments in both cutting-edge intravenous iron therapies and the necessary infrastructure, including catheters, to support these treatments. Consequently, advancements in intravenous iron formulations are becoming a key driver of growth for the intravascular catheters market, with long-term prospects for continued market expansion.
Restraints:
- High cost of IV iron therapies
- Adverse reactions limit patient compliance
- Limited infrastructure in developing regions
- Stringent drug approval and safety protocols - Major challenge for the global intravascular catheters market. Regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and similar bodies worldwide impose strict compliance standards to ensure that medical devices meet high benchmarks for safety, efficacy, and quality. Because intravascular catheters are inserted directly into the bloodstream, they undergo intensive scrutiny before gaining market authorization. The process involves detailed clinical evaluations, exhaustive testing, and thorough documentation, all of which can result in lengthy delays and higher development costs for manufacturers.
Compounding this challenge is the global inconsistency in regulatory frameworks. Manufacturers aiming for international market penetration must comply with diverse and often complex regional requirements, such as country-specific clinical protocols, product labeling regulations, and post-market surveillance obligations. These variances make it difficult for companies, particularly smaller firms or startups, to streamline their go-to-market strategies. The financial and operational burden of meeting these obligations often deters innovation and slows the introduction of new and advanced catheter technologies.
The risk of product recalls or regulatory action further heightens the pressure. Even minor issues related to safety, manufacturing errors, or adverse patient events can prompt stringent regulatory reviews, legal complications, or even market withdrawals. As a result, companies are compelled to invest heavily in pre-market validation, risk management, and ongoing quality control to avoid non-compliance. While this ensures patient safety, it significantly extends development timelines and inflates production costs, creating barriers for emerging players in the market.
Opportunities:
- Untapped potential in emerging economies
- Expanding applications in oncology care
- R&D in safer iron drug variants
- Collaborations boosting global market penetration - Strategic collaborations are playing a vital role in accelerating global market penetration within the intravascular catheters industry. These partnerships—whether between medical device manufacturers, healthcare providers, research institutions, or regulatory bodies—are fostering innovation and expanding the reach of catheter technologies worldwide. By joining forces, companies can pool technical expertise and financial resources to develop advanced, minimally invasive solutions that meet the growing global demand for safer and more effective vascular access tools.
Collaborations are especially crucial in accessing emerging markets. Through alliances with regional distributors or local healthcare systems, global manufacturers can navigate diverse regulatory frameworks, localize product offerings, and gain valuable insights into region-specific clinical needs. This not only speeds up market entry but also increases product acceptance among healthcare professionals. Additionally, these partnerships often lead to setting up regional production hubs, reducing logistical costs and ensuring a faster, more reliable supply chain.
Joint efforts with academic and clinical research centers are also driving significant advancements in catheter design, materials, and safety features. These innovations—often backed by rigorous clinical data—are helping companies achieve faster regulatory approvals and greater trust among end-users. The result is a pipeline of next-generation intravascular catheters that address critical needs such as infection prevention, ease of insertion, and patient comfort, ultimately enhancing their competitiveness in global markets.
Competitive Landscape Analysis
Key players in Global Intravascular Catheters Market include:
- Cook Medical
- Smiths Medical
- Edwards Life Sciences Corporation
- Medtronic Inc.
- Johnson & Johnson
- McKesson Medical Surgical Inc.
- Terumo Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Appliation
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Intravascular Catheters Market DynamicsOpportunities
- Drivers, Restraints and Opportunities
- Drivers
- Growing burden of iron deficiency disorders
- Rising CKD and dialysis-related anemia
- Demand for rapid iron repletion methods
- Advancements in intravenous iron formulations
- Drivers
- Restraints
- High cost of IV iron therapies
- Adverse reactions limit patient compliance
- Limited infrastructure in developing regions
- Stringent drug approval and safety protocols
- Opportunities
- Innovation in antimicrobial catheter technology
- Growth in outpatient and home care
- Rising adoption in emerging healthcare markets
- Drivers, Restraints and Opportunities
Expanding geriatric patient population globally
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Market Segmentation
- Global Intravascular Catheters Market, By Product, 2021 - 2031 (USD Million)
-
Short
-
Integrated/Closed PIVCs
-
- Global Intravascular Catheters Market, By Application, 2021 - 2031 (USD Million)
- Oncology
- Gastroenterology
- Renal Disease
- Infectious Diseases
- Others
-
Global Intravascular Catheters Market, By End Use, 2021 - 2031 (USD Million)
-
Hospitals
-
Clinics
-
ASC
-
Homecare
-
- Global Intravascular Catheters Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Intravascular Catheters Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Cook Medical
- Smiths Medical
- Edwards Life Sciences Corporation
- Medtronic Inc.
- Johnson & Johnson
- McKesson Medical Surgical Inc.
- Terumo Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market